{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T06:19:58Z","timestamp":1782886798515,"version":"3.54.5"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T00:00:00Z","timestamp":1762128000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100030898","name":"Institut canadien d'information sur la sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000226","name":"Ontario Ministry of Health and Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025090","name":"Ministry of Long-Term Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025090","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012665","name":"Institute for Clinical Evaluative Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.jtha.2025.10.027","type":"journal-article","created":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T02:59:20Z","timestamp":1762570760000},"page":"1000-1013","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Association of direct oral anticoagulant\u2013anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1111-919X","authenticated-orcid":false,"given":"Stephanie","family":"Carlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M.","family":"Holbrook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Candeloro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Paterson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Douketis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.10.027_bib1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.10.027_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000001193","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"149","author":"Joglar","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.10.027_bib3","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2025.10.027_bib4","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2025.10.027_bib5","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.jacc.2019.12.068","article-title":"Select drug-drug interactions with direct oral anticoagulants: JACC review topic of the week","volume":"75","author":"Wiggins","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jtha.2025.10.027_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.yebeh.2020.107550","article-title":"Trends in oral anticoagulant co-prescription with antiepileptic drugs among adults with epilepsy, 2010-2018","volume":"113","author":"Acton","year":"2020","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.jtha.2025.10.027_bib11","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s40263-021-00795-z","article-title":"Effect of enzyme-inducing antiseizure medications on the risk of sub-therapeutic concentrations of direct oral anticoagulants: a retrospective cohort study","volume":"35","author":"Perlman","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jtha.2025.10.027_bib12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.amjmed.2021.06.003","article-title":"The impact of strong inducers on direct oral anticoagulant levels","volume":"134","author":"Sennesael","year":"2021","journal-title":"Am J Med"},{"key":"10.1016\/j.jtha.2025.10.027_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/rth2.12650","article-title":"Carbamazepine, phenytoin, and oral anticoagulants: drug-drug interaction and clinical events in a retrospective cohort","volume":"6","author":"Candeloro","year":"2022","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.027_bib14","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s40263-019-00677-5","article-title":"Ischemic and thrombotic events associated with concomitant Xa-inhibiting direct oral anticoagulants and antiepileptic drugs: analysis of the FDA Adverse Event Reporting System (FAERS)","volume":"33","author":"Perlman","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jtha.2025.10.027_bib15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/cpt.1845","article-title":"Pharmacoepidemiologic screening of potential oral anticoagulant drug interactions leading to thromboembolic events","volume":"108","author":"Zhou","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtha.2025.10.027_bib16","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1002\/cpt.2369","article-title":"Association between use of pharmacokinetic-interacting drugs and effectiveness and safety of direct acting oral anticoagulants: nested case-control study","volume":"110","author":"Gronich","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jtha.2025.10.027_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.100137","article-title":"Drug-drug interactions between direct oral anticoagulants and anticonvulsants and clinical outcomes: a systematic review","volume":"7","author":"Candeloro","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.10.027_bib18","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/jamaneurol.2024.2057","article-title":"Direct-acting oral anticoagulants and antiseizure medications for atrial fibrillation and epilepsy and risk of thromboembolic events","volume":"81","author":"Acton","year":"2024","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.jtha.2025.10.027_bib19","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1093\/europace\/euab218","article-title":"2021 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation: comment\u2014authors\u2019 reply","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"10.1016\/j.jtha.2025.10.027_bib20","doi-asserted-by":"crossref","first-page":"9257","DOI":"10.1038\/s41598-023-33876-8","article-title":"The efficacy of direct oral anticoagulants in patients on concomitant treatment with levetiracetam","volume":"13","author":"Mavri","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jtha.2025.10.027_bib21","article-title":"The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE)","volume":"363","author":"Langan","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2025.10.027_bib22","series-title":"Personal Health Information Protection Act, 2004, S.O. 2004, c.3, Sched. A. Legislative Assembly of Ontario","year":"2004"},{"key":"10.1016\/j.jtha.2025.10.027_bib23","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1080\/03610910902859574","article-title":"Using the standardized difference to compare the prevalence of a binary variable between two groups in observational research","volume":"38","author":"Austin","year":"2009","journal-title":"Commun Stat Simulat Comput"},{"key":"10.1016\/j.jtha.2025.10.027_bib24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/j.jtha.2025.10.027_bib25","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","article-title":"Propensity score methods for confounding control in nonexperimental research","volume":"6","author":"Brookhart","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/j.jtha.2025.10.027_bib26","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1002\/sim.6607","article-title":"Moving towards best practice when using inverse probability of treatment weighting (IPTW) using the propensity score to estimate causal treatment effects in observational studies","volume":"34","author":"Austin","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/j.jtha.2025.10.027_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.seizure.2021.05.006","article-title":"Efficacy of phenobarbital in treating elderly epilepsy patients in rural northeast China: a community-based intervention trial","volume":"89","author":"Li","year":"2021","journal-title":"Seizure"},{"key":"10.1016\/j.jtha.2025.10.027_bib28","doi-asserted-by":"crossref","first-page":"E877","DOI":"10.9778\/cmajo.20200055","article-title":"Comparative effectiveness and safety of direct oral anticoagulants versus vitamin K antagonists in nonvalvular atrial fibrillation: a Canadian multicentre observational cohort study","volume":"8","author":"Durand","year":"2020","journal-title":"CMAJ Open"},{"key":"10.1016\/j.jtha.2025.10.027_bib29","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007129","article-title":"Temporal trends in the use and comparative effectiveness of direct oral anticoagulant agents versus warfarin for nonvalvular atrial fibrillation: a Canadian population-based study","volume":"6","author":"Yu","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jtha.2025.10.027_bib30","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/6707985","article-title":"Time trends and treatment pathways in prescribing individual oral anticoagulants in patients with nonvalvular atrial fibrillation: an observational study of more than three million patients from Europe and the United States","volume":"2022","author":"Vora","year":"2022","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.jtha.2025.10.027_bib31","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1159\/000449288","article-title":"How reliable are administrative data for capturing stroke patients and their care","volume":"6","author":"Porter","year":"2016","journal-title":"Cerebrovasc Dis Extra"},{"key":"10.1016\/j.jtha.2025.10.027_bib32","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.thromres.2015.10.035","article-title":"Identifying venous thromboembolism and major bleeding in emergency room discharges using administrative data","volume":"136","author":"Al-Ani","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.10.027_bib33","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1161\/01.STR.0000174293.17959.a1","article-title":"Coding of stroke and stroke risk factors using international classification of diseases, revisions 9 and 10","volume":"36","author":"Kokotailo","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.jtha.2025.10.027_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.thromres.2005.06.015","article-title":"Accuracy of coding for possible warfarin complications in hospital discharge abstracts","volume":"118","author":"Arnason","year":"2006","journal-title":"Thromb Res"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625007275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625007275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,14]],"date-time":"2026-06-14T16:04:16Z","timestamp":1781453056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625007275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S1538783625007275"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.10.027","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of direct oral anticoagulant\u2013anticonvulsant coprescription with clinical outcomes in older adults: a population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.10.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}